Revenue Cycle Challenges & Solutions for Hematology Practices in 2026
Hematology RCM mirrors oncology complexity: biologics, infusions, prior auths. Explore 2026 challenges and solutions for stronger profitability.
Hematology deals with blood disorders/cancers using costly biologics and infusions creating parallel RCM issues to oncology but often with fewer dedicated resources.
Key 2026 Challenges:
– HCPCS coding for blood products, infusions, and targeted therapies.
– Prior auth/medical necessity reviews.
– Patient collections amid high responsibility.
– Documentation for appeals.
Solutions:
– Dedicated infusion workflows and coding audits.
– Benefits verification + counseling.
– Pattern-based denial management.
– Compliance with annual CMS updates.
Our 15–20+ years in hematology/onco deliver precise fixes turning leaks into cash.